<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto de Ensino e Pesquisa Albert Einstein</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25946050</article-id>
      <article-id pub-id-type="pmc">4943821</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082015RC2793</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082015RC2793</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Renal hemangiopericytoma: case report and literature review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Vetorazzo</surname>
            <given-names>Jos&#xE9; Eduardo</given-names>
            <suffix>Filho</suffix>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bahia</surname>
            <given-names>Leandro Augusto Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Esteves</surname>
            <given-names>Paulo Ebert</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maron</surname>
            <given-names>Paulo Eduardo Goulart</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vedovato</surname>
            <given-names>Bruno C&#xE9;sar</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Roni de Carvalho</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Perez</surname>
            <given-names>Marjo Deninson Cardenuto</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brazil.</aff>
      <aff id="aff2"><label>2</label>Faculdade de Ci&#xEA;ncias M&#xE9;dicas da Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brazil.</aff>
      <author-notes>
        <corresp id="c01"><label>Corresponding author</label>: Jos&#xE9; Eduardo Vetorazzo Filho &#x2212; Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo, Rua Doutor Ces&#xE1;rio Mota J&#xFA;nior, 112 &#x2212; Vila Buarque &#x2212; Zipe code: 01221-020 &#x2212; S&#xE3;o Paulo, SP, Brazil Phone: (55 11) 2176-7000 &#x2212; E-mail: <email>jevetorazzo@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>13</volume>
      <issue>2</issue>
      <fpage>269</fpage>
      <lpage>272</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>3</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Hemangioperycytoma is a rare perivascular tumor that seldom involves the urogenital system. This tumor often appears with an unspecific clinical picture, and sometimes is associated with hematuria or hypertension. Diagnosis is based on a combination of histological and immunohistological findings. We report a case of a 52-year-old patient with renal hemangiopericytoma who underwent surgical treatment at our service. This report also includes a literature review on the subject.</p>
      </abstract>
      <kwd-group>
        <kwd>Hemangiopericytoma/diagnosis</kwd>
        <kwd>Urologic neoplasms</kwd>
        <kwd>Vascular neoplasms</kwd>
        <kwd>Muscle, smooth</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="12"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="7"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Hemangiopericytoma (HPC) was first described in 1942. This is a rare perivascular tumor due to uncontrolled proliferation capillary pericytes. This tumor affects mainly extremities of the body, pelvis, head and neck, and meningitis, but hemangiopericytoma is rarely found in urogenital system. Until 2009, only 42 cases of this neoplasia involving the kidney were reported in the world literature.<sup>(</sup>
<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup>
</p>
      <p>Because of the rarity of this injury until to date, no therapeutic management and ideal diagnosis were established as well as progress and prognosis of the disease.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> We report a case of renal HPC diagnosed and treated at Urological Service of the <italic>Irmandade Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo</italic>.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>In November 2011, a 52-year-old, white and previously healthy woman was admitted at our because of an increase in abdominal volume. She denied any other complains, including abdominal pain or hematuria. The patient does not have a history of smoking or use of illicit substances. In March 2012, she began a follow-up at outpatient unit dedicated to urology care. She had blood hypertension and took medicine for this affection, and also mentioned to lose 10kg in that period. Her ultrasonography test of urinary tract showed evidence of tumors in topography of the right kidney. Laboratorial tests showed anemia with serum hemoglobin value of 8.9g/dL. The abdominal computed tomography (CT) scan revealed a cystic-solid expansive formation, multiloculated, heterogenous in the right kidney that replaced the parenchyma in the medial and inferior third. The formation measured 23.2x18.8x18.7cm with special emphasis of solid portions and superimposition of septal segments that dislocated superiorly the liver and gallbladder, crossing the medium line and opposing medially to the pancreas, portal and aortic vein with signs of vascular compromising (<xref rid="f01" ref-type="fig">Figure 1</xref>).</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Tomography showing abdominal tumor</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf01"/></fig>
</p>
      <p>The patient had undergone radical nephrectomy, which is a procedure with technical difficult because of tumor proportion, without intercurrence or necessity of blood transfusion, and even intensive care in immediate postoperative. Patient progressed without complications, her drain presented low debt and good diuresis. She was discharged on the 3rd day after the surgery.</p>
      <p>The anatomopathological study (<xref rid="f02" ref-type="fig">Figure 2</xref>) confirmed the diagnosis of HPC, and immunohistochemical analysis showed tumoral cells positive for BCL-2 (<xref rid="f03" ref-type="fig">Figure 3</xref>), CD99 (<xref rid="f04" ref-type="fig">Figure 4</xref>), vimentin (<xref rid="f05" ref-type="fig">Figure 5</xref>), CD34 (<xref rid="f06" ref-type="fig">Figure 6</xref>), and negative for S-100. Mitotic index score was 2 (13 mitoses per 10 high-power fields).</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Histological analysis with hematoxylin-eosin</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf02"/></fig>
</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Immunohistochemical with positive CD99 staining</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf03"/></fig>
</p>
      <p>
<fig id="f04" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Immunohistochemical with positive BCL-2 staining</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf04"/></fig>
</p>
      <p>
<fig id="f05" orientation="portrait" position="float"><label>Figure 5</label><caption><title>Immunohistochemical with positive vimentin staining</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf05"/></fig>
</p>
      <p>
<fig id="f06" orientation="portrait" position="float"><label>Figure 6</label><caption><title>Immunohistochemical with positive CD34 staining</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf06"/></fig>
</p>
      <p>In return visit at outpatient unit, the patient remained asymptomatic and without local or systemic complications. We removed points of surgical incision and requested abdominal CT and control chest radiography for 4 months. During reassessments on this period the patient was in good general status, normotensive and did not need anti-hypertensive medicine. In addition, no other complaints were reported. Radiography exam showed changes and CT revealed only sings of previous manipulations in topography of right kidney and mild increased paracaval lymph nodes, &lt;1.0cm. Currently, 7th months after surgery, the patient is clinically well and without intercurrence.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>HPC is classified as vascular tumor of soft tissues from the pericytes, modified cells of smooth muscle tissue that were described by Zimmerman in 1923. Such cells are organized around capillaries and post-capillary veins, and they are responsible to modulate blood flow and permeability of these vessels.<sup>(</sup>
<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup>
</p>
      <p>Our patient was at average age of diagnosis of this neoplasia, about 40.3 years old (16 to 68 years old), which suggest that such tumor affect more frequently in young patients than other types of renal cell cancer.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>) </sup>No significant difference is found concerning the incidence of this neoplasia between men and women, and no age variation between sexes in the diagnosis.</p>
      <p>Clinical picture is unspecific. In 66% of cases reported in the literature, initial symptom is painless abdominal tumor, such as reported in our case. Other symptoms already described, in order of frequency, are: hematuria, hypoglycemia and arterial hypertension.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> A study reported that hematuria was found in six patients in which an invasion of pyelocaliceal system by tumor occured.<sup>(</sup>
<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup> Hypoglycemia is also associated to excess of glucose metabolism by the tumor. Blood hypertension, however, is believed to occur because of the production of renin by the neoplasia and, as observed in our patient, it often disappear after surgical treatment.<sup>(</sup>
<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>) </sup>The most common site of metastasis of renal HPC is the lung, which was described in two case and patients had a poor prognosis.</p>
      <p>Imaging exams, such as ultrasonography, CT or magnetic resonance did not show specific finding of the tumor that were able to collaborate in the differential diagnosis from other renal tumors.<sup>(</sup>
<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> However, Yagmani reported that these tumors can have standard characteristic in early phase of blood angiography &#x2013; of principal arteries, presence of vessels surrounding the tumor and well-marked stain, delimiting the tumor.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>
</p>
      <p>Macroscopically, most tumors are well circumscribed lesions or a thin capsule, associated to complex network of vessels and, sometimes, with small satellite nodules around the main mass. Only the minority is adhered to neighbouring tissues. Tumor size reported in the literature range between 2 and 25cm.<sup>(</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>
</p>
      <p>In general, there is a cellular proliferation with small variability in cellularity, a &#x201C;staghorn&#x201D; vascular pattern with packed pericytes around vascular endothelium, and minimal collagenization that can vary both in size and form. The technique used is based on Hematoxylin and eosin stain (<xref rid="f02" ref-type="fig">Figure 2</xref>) and silver associated with immunohistochemistry, using antibodies against CD31, CD34, CD99, S-100, vimentin, citokeratin and epithelia antigen membrane (renal). Only the combination of these two is can provide the diagnosis,<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> which in our case enabled the precise diagnosis of tumoral mass.</p>
      <p>HPC diagnosis is done mainly by exclusion. The histological pattern and immunophenotyping provide information to differential diagnosis with other vascular neoplasias and other mesenchymal tumors. Such tumors include juxtaglomerular origin, which often is presented as blood hypertension, especially in young adults. These tumors are considered of different origin of HPC.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Other vascular neoplasias, histiocytosis, neural and of smooth muscle must be excluded before the definitive diagnosis of HPC.<sup>(</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>
</p>
      <p>The main treatment for this disease is surgery, and exeresis must be as radical as possible in order to avoid incomplete resection and recurrence. Therefore, an appropriate surgical plan associated with a previous study of tumor vascular architecture (CT angiography or arteriography) must be done.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Radiotherapy, chemotherapy or adjuvant or neoadjuvant immunotherapy seem to be inefficient to treat HPC. Although, the majority of renal HPCs are benign, outcomes cannot be precisely foreseen by histological appearance, however, rigorous follow-up must be conducted to detect long-term recurrence.<sup>(</sup>
<xref rid="B6" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
      <p>Main factor associated to prognosis seems to be the histological pattern. Enzinger and Smith observed survival of 77% in 10 years in patients with 0 to 3 mitoses /10 <italic>versus</italic> 29% in those patients with 4 or more by field.<sup>(</sup>
<xref rid="B7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> Similarly, survival was 81% in patients with tumoral necrosis <italic>versus </italic>29% in those who had necrotic areas in the tumor. They also observed the importance of tumor size concerning prognosis. In tumors &lt;6.5cm, survival in 10 years reached 95% and 63% for large tumors.<sup>(</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>
</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>Because HPC is rare and present a vague clinical picture associated with imaging exams that do not indicate a specific disease, the precisely diagnosis of hemangiopericytoma is made only after surgery and with the immunohistochemical result.</p>
      <p>Best treatment consists in complete surgical excision because complementary treatment such as chemotherapy and/or radiotherapy is not efficient.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bilici</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ustaalioglu</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Seker</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Salman</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Igdem</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Celik</surname>
              <given-names>E</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Metastatic renal hemangiopericytoma: A rare case report</article-title>
          <source>Arch Oncol</source>
          <year>2009</year>
          <volume>17</volume>
          <issue>1-2</issue>
          <fpage>32</fpage>
          <lpage>35</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Argyropoulos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Liakatas</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lykourinas</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Renal haemangiopericytoma: the characteristics of a rare tumour</article-title>
          <source>BJU Int</source>
          <year>2005</year>
          <volume>95</volume>
          <issue>7</issue>
          <fpage>943</fpage>
          <lpage>947</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">15839909</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stout</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Hemangiopericytoma a vascular tumor featuring Zimmermann&#x2019;s pericytes</article-title>
          <source>Ann Surg</source>
          <year>1942</year>
          <volume>116</volume>
          <issue>1</issue>
          <fpage>26</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">17858068</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brescia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gardi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maria Vecchio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bassi</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Renal Hemangiopericytoma: case report and review of the literature</article-title>
          <source>Urology</source>
          <year>2008</year>
          <volume>71</volume>
          <issue>4</issue>
          <size units="pages">755</size>
          <fpage>e9</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">18387402</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yaghmai</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Angiographic manifestations of soft-tissue and osseous hemangiopericytomas</article-title>
          <source>Radiology</source>
          <year>1978</year>
          <volume>126</volume>
          <issue>3</issue>
          <fpage>653</fpage>
          <lpage>659</lpage>
          <pub-id pub-id-type="pmid">628734</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaudhary</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Seenu</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sedain</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ray</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>S</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Hemangiopericytoma of renal pelvis &#x2013; an unusual tumor in an adolescent</article-title>
          <source>Urology</source>
          <year>2007</year>
          <volume>70</volume>
          <issue>4</issue>
          <size units="pages">811</size>
          <fpage>e13</fpage>
          <lpage>e14</lpage>
          <pub-id pub-id-type="pmid">17991570</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Enzinger</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>BH</given-names>
            </name>
          </person-group>
          <article-title>Hemangiopericytoma. An analysis of 106 cases</article-title>
          <source>Hum Pathol</source>
          <year>1976</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>61</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">1244311</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="TRpt" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hemangiopericitoma renal: relato de caso e revis&#xE3;o de literatura</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Vetorazzo</surname>
            <given-names>Jos&#xE9; Eduardo</given-names>
            <suffix>Filho</suffix>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bahia</surname>
            <given-names>Leandro Augusto Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Esteves</surname>
            <given-names>Paulo Ebert</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maron</surname>
            <given-names>Paulo Eduardo Goulart</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vedovato</surname>
            <given-names>Bruno C&#xE9;sar</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Roni de Carvalho</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Perez</surname>
            <given-names>Marjo Deninson Cardenuto</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1002"><label>1</label>Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brasil.</aff>
      <aff id="aff2002"><label>2</label>Faculdade de Ci&#xEA;ncias M&#xE9;dicas da Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brasil.</aff>
      <author-notes>
        <corresp id="c01002"> Autor correspondente: Jos&#xE9; Eduardo Vetorazzo Filho &#x2212; Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo, Rua Doutor Ces&#xE1;rio Mota J&#xFA;nior, 112 &#x2212; Vila Buarque &#x2212; CEP: 01221-020 &#x2212; S&#xE3;o Paulo, SP, Brasil Tel.: (11) 2176-7000 &#x2212; E-mail: jevetorazzo@gmail.com </corresp>
      </author-notes>
      <abstract>
        <p>Hemangiopericitoma &#xE9; um raro tumor perivascular que raramente envolve o sistema urogenital. Esses tumores geralmente se manifestam com quadro cl&#xED;nico inespec&#xED;fico, por vezes associado a hemat&#xFA;ria ou hipertens&#xE3;o. O diagn&#xF3;stico baseia-se numa combina&#xE7;&#xE3;o de altera&#xE7;&#xF5;es histol&#xF3;gicas e imuno-histol&#xF3;gica. Este artigo relatou o caso de uma paciente de 52 anos de idade com um hemangiopericitoma renal submetida a tratamento cir&#xFA;rgico em nosso servi&#xE7;o e incluiu uma revis&#xE3;o de literatura sobre o assunto.</p>
      </abstract>
      <kwd-group>
        <kwd>Hemangiopericitoma/diagn&#xF3;stico</kwd>
        <kwd>Neoplasias urol&#xF3;gicas</kwd>
        <kwd>Neoplasias vasculares</kwd>
        <kwd>M&#xFA;sculo liso</kwd>
        <kwd>Relatos de casos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>INTRODU&#xC7;&#xC3;O</title>
        <p>Descrito pela primeira vez em 1942, o hemangiopericitoma (HPC) &#xE9; um raro tumor perivascular resultante da prolifera&#xE7;&#xE3;o descontrolada dos pericitos capilares. Acometem principalmente extremidades, pelve, cabe&#xE7;a e pesco&#xE7;o, e meninges, sendo raramente encontrados no sistema urogenital. At&#xE9; 2009, apenas 42 casos dessa neoplasia envolvendo o rim foram relatados na literatura mundial.<sup>(</sup>
<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup>
</p>
        <p>Devido a raridade dessas les&#xF5;es, at&#xE9; os dias atuais, n&#xE3;o est&#xE3;o estabelecidas condutas terap&#xEA;uticas e diagn&#xF3;sticas ideais, nem a evolu&#xE7;&#xE3;o e o progn&#xF3;stico da doen&#xE7;a.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Relatamos um caso de HPC renal diagnosticado e tratado no Servi&#xE7;o de Urologia da Irmandade Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo.</p>
      </sec>
      <sec>
        <title>RELATO DE CASO</title>
        <p>Paciente de 52 anos de idade, do g&#xEA;nero feminino, branca, previamente h&#xED;gida, apresentou, em novembro de 2011, aumento do volume abdominal. Negava qualquer outra queixa, incluindo dor abdominal ou hemat&#xFA;ria. N&#xE3;o tinha hist&#xF3;ria de tabagismo ou de uso de subst&#xE2;ncias il&#xED;citas. Em mar&#xE7;o de 2012 come&#xE7;ou o acompanhamento ambulatorial no servi&#xE7;o de urologia, hipertensa em uso de medica&#xE7;&#xF5;es e referindo perda de 10kg nesse per&#xED;odo; trouxe ultrassonografia das vias urin&#xE1;rias com evid&#xEA;ncia de tumora&#xE7;&#xE3;o em topografia do rim direito. Exames laboratoriais revelaram anemia, com valor s&#xE9;rico de hemoglobina de 8,9g/dL. Tomografia computadorizada (TC) de abdome evidenciou forma&#xE7;&#xE3;o expansiva s&#xF3;lido-c&#xED;stica, multisseptada, heterog&#xEA;nea, com origem no rim direito, substituindo o par&#xEA;nquima, no ter&#xE7;o m&#xE9;dio e inferior, medindo 23,2x18,8x18,7cm, com realce das por&#xE7;&#xF5;es s&#xF3;lidas e dos septos de permeio, deslocando superiormente o f&#xED;gado e a ves&#xED;cula biliar, cruzando a linha m&#xE9;dia e recha&#xE7;ando medialmente o p&#xE2;ncreas, veia porta e aorta, sem sinais de comprometimento vascular (<xref rid="f01002" ref-type="fig">Figura 1</xref>).</p>
        <p>
<fig id="f01002" orientation="portrait" position="float"><label>Figura 1</label><caption><title>Tomografia evidenciando tumora&#xE7;&#xE3;o abdominal</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf01-pt"/></fig>
</p>
        <p>Foi submetida a nefrectomia radical, procedimento com dificuldade t&#xE9;cnica devido &#xE0;s propor&#xE7;&#xF5;es da tumora&#xE7;&#xE3;o, por&#xE9;m sem intercorr&#xEA;ncias, n&#xE3;o necessitando de transfus&#xE3;o sangu&#xED;nea e nem de cuidados intensivos no p&#xF3;s-operat&#xF3;rio imediato. A paciente evoluiu sem complica&#xE7;&#xF5;es, dreno com baixo d&#xE9;bito e boa diurese, tendo alta no 3<sup><underline>o</underline></sup> dia ap&#xF3;s a cirurgia.</p>
        <p>Estudo anatomopatol&#xF3;gico (<xref rid="f02002" ref-type="fig">Figura 2</xref>) confirmou o diagn&#xF3;stico de HPC, e a an&#xE1;lise imuno-histoqu&#xED;mica mostrou c&#xE9;lulas tumorais positivas para BCL-2 (<xref rid="f03002" ref-type="fig">Figura 3</xref>), CD99 (<xref rid="f04002" ref-type="fig">Figura 4</xref>), vimentina (<xref rid="f05002" ref-type="fig">Figura 5</xref>), CD34 (<xref rid="f06002" ref-type="fig">Figura 6</xref>), sendo negativo para S-100. O &#xED;ndice mit&#xF3;tico teve escore de 2 (13 mitoses por 10 campos de grande aumento).</p>
        <p>
<fig id="f02002" orientation="portrait" position="float"><label>Figura 2</label><caption><title>An&#xE1;lise histol&#xF3;gica com hematoxilina-eosina</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf02-pt"/></fig>
</p>
        <p>
<fig id="f03002" orientation="portrait" position="float"><label>Figura 3</label><caption><title>Imuno-histoqu&#xED;mica com marcador CD99 positivo</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf03-pt"/></fig>
</p>
        <p>
<fig id="f04002" orientation="portrait" position="float"><label>Figura 4</label><caption><title>Imuno-histoqu&#xED;mica com marcador BCL-2 positivo</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf04-pt"/></fig>
</p>
        <p>
<fig id="f05002" orientation="portrait" position="float"><label>Figura 5</label><caption><title>Imuno-histoqu&#xED;mica com marcador vimentina positivo</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf05-pt"/></fig>
</p>
        <p>
<fig id="f06002" orientation="portrait" position="float"><label>Figura 6</label><caption><title>Imuno-histoqu&#xED;mica com marcador CD34 positivo</title></caption><graphic xlink:href="1679-4508-eins-13-2-0269-gf06-pt"/></fig>
</p>
        <p>No retorno ambulatorial, permanecia assintom&#xE1;tica e sem complica&#xE7;&#xF5;es locais ou sist&#xEA;micas. Foram retirados os pontos da incis&#xE3;o cir&#xFA;rgica e solicitado TC abdominal e radiografia de t&#xF3;rax controle em 4 meses. &#xC0; reavalia&#xE7;&#xE3;o nesse per&#xED;odo, novamente encontrava-se em bom estado geral, normotensa e sem necessidade de usar anti-hipertensivos, sem qualquer queixa. A radiografia n&#xE3;o mostrou altera&#xE7;&#xF5;es e a TC revelou apenas sinais de manipula&#xE7;&#xE3;o pregressa em topografia de rim direito e linfonodos pericavais discretamente aumentados, &lt;1,0cm. Atualmente no 7<sup><underline>o</underline></sup> m&#xEA;s p&#xF3;s-operat&#xF3;rio, a paciente mant&#xE9;m-se clinicamente bem, sem intercorr&#xEA;ncias p&#xF3;s-operat&#xF3;rias.</p>
      </sec>
      <sec>
        <title>DISCUSS&#xC3;O</title>
        <p>HPC &#xE9; classificado como um tumor vascular de tecidos moles originado a partir de pericitos, c&#xE9;lulas modificadas de m&#xFA;sculo liso, descritas por Zimmerman, em 1923. Tais c&#xE9;lulas se arranjam ao redor de capilares e veias p&#xF3;s-capilares, sendo respons&#xE1;veis por modular o fluxo sangu&#xED;neo e pela permeabilidade de tais vasos.<sup>(</sup>
<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup>
</p>
        <p>A paciente relatada encontrava-se na m&#xE9;dia de idade de diagn&#xF3;stico dessa neoplasia, pr&#xF3;ximo de 40,3 anos (16 a 68 anos), sugerindo que tal tumor ocorre com maior frequ&#xEA;ncia em pacientes jovens que outros tipos de carcinomas de c&#xE9;lulas renal.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> N&#xE3;o h&#xE1; diferen&#xE7;a significativa quanto a incid&#xEA;ncia entre homens e mulheres, e nem varia&#xE7;&#xE3;o de idade entre os g&#xEA;neros ao diagn&#xF3;stico.</p>
        <p>O quadro cl&#xED;nico &#xE9; inespec&#xED;fico. Em 66% dos casos relatados na literatura, o sintoma inicial foi de tumora&#xE7;&#xE3;o abdominal indolor, assim como o relatado neste caso. Outros sintomas j&#xE1; descritos, em ordem de frequ&#xEA;ncia, s&#xE3;o: hemat&#xFA;ria, hipoglicemia e hipertens&#xE3;o arterial.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Hemat&#xFA;ria foi detectada em seis pacientes, nos quais houve invas&#xE3;o do sistema pielo-calicinal pelo tumor.<sup>(</sup>
<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>) </sup>Hipoglicemia foi associada ao excessivo metabolismo de glicose pelo tumor. J&#xE1; a hipertens&#xE3;o arterial acredita-se que seja decorrente de produ&#xE7;&#xE3;o de renina pela neoplasia e, assim como evidenciado em nossa paciente, geralmente regride ap&#xF3;s o tratamento cir&#xFA;rgico.<sup>(</sup>
<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> O s&#xED;tio mais frequente de met&#xE1;stases do HPC renal &#xE9; o pulm&#xE3;o, descrito em dois casos, nos quais houve pior progn&#xF3;stico dos doentes.</p>
        <p>Exames de imagem, como ultrassonografia, TC ou resson&#xE2;ncia magn&#xE9;tica, n&#xE3;o demonstram achados espec&#xED;ficos do tumor que pudessem colaborar para o diagn&#xF3;stico diferencial entre outras neoplasias renais.<sup>(</sup>
<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> Por outro lado, Yaghmai mostrou que esses tumores podem ter um padr&#xE3;o caracter&#xED;stico na fase precoce da angiografia arterial &#x2212; das art&#xE9;rias principais, presen&#xE7;a de grandes vasos circundando o tumor e uma mancha bem demarcada, delimitando o tumor.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>
</p>
        <p>Macroscopicamente a maioria dos tumores se manifesta como les&#xF5;es bem delimitadas ou com uma fina c&#xE1;psula, associada a uma ampla rede de vasos e, por vezes, com n&#xF3;dulos sat&#xE9;lites pequenos encontrados separadamente da massa. Apenas uma minoria est&#xE1; aderida a tecidos vizinhos. O tamanho dos tumores relatados na literatura varia entre 2 e 25cm.<sup>(</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>
</p>
        <p>Geralmente, h&#xE1; prolifera&#xE7;&#xE3;o celular com pequena varia&#xE7;&#xE3;o da celularidade, com padr&#xE3;o vascular em &#x201C;chifre de alce&#x201D; com pericitos embalados em torno de endot&#xE9;lio vascular, e m&#xED;nima colageniza&#xE7;&#xE3;o, podendo variar tanto em forma quanto em tamanho. A t&#xE9;cnica utilizada baseia-se na colora&#xE7;&#xE3;o por hematoxilina-eosina (<xref rid="f02002" ref-type="fig">Figura 2</xref>) e de prata, em associa&#xE7;&#xE3;o com imuno-histoqu&#xED;mica, utilizando anticorpos contra CD31, CD34, CD99, S-100, vimentina, citoqueratinas e ant&#xED;geno de membrana epitelial (renal). Apenas a combina&#xE7;&#xE3;o dos dois &#xE9; capaz de prover o diagn&#xF3;stico,<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> o que permitiu o diagn&#xF3;stico de certeza da massa tumoral do caso apresentado.</p>
        <p>O diagn&#xF3;stico de HPC &#xE9; principalmente de exclus&#xE3;o. O padr&#xE3;o histol&#xF3;gico e a imunofenotipagem fornecem informa&#xE7;&#xE3;o para o diagn&#xF3;stico diferencial com outras neoplasias vasculares e outros tumores mesenquimais. Tais tumores incluem os de origem justaglomerular, que geralmente apresentam-se com hipertens&#xE3;o arterial, especialmente em adultos jovens. Esses tumores s&#xE3;o considerados de origem diferente do HPC.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Outras neoplasias vasculares, histiocit&#xE1;rias, neurais e do m&#xFA;sculo liso devem ser exclu&#xED;das antes de se definir o diagn&#xF3;stico de HPC.<sup>(</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>
</p>
        <p>Cirurgia &#xE9; considerada o tratamento principal para tal patologia, e a ex&#xE9;rese deve ser o mais radical poss&#xED;vel, a fim de evitar ressec&#xE7;&#xE3;o incompleta e recidiva. Portanto, um apropriado plano cir&#xFA;rgico, associado a um estudo da arquitetura vascular tumoral (angio-TC ou arteriografia) pr&#xE9;vio, deve ser realizado.<sup>(</sup>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Radioterapia, quimioterapia ou imunoterapia adjuvantes ou neoadjuvantes n&#xE3;o pareceram ser eficazes para o HPC. Embora a maioria dos HPC renais seja benigna, o desfecho n&#xE3;o pode ser precisamente previsto pela apar&#xEA;ncia histol&#xF3;gica, mas deve ser realizado acompanhamento rigoroso para detectar recorr&#xEA;ncia a longo prazo.<sup>(</sup>
<xref rid="B6" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
        <p>O principal fator associado ao progn&#xF3;stico parece ser o padr&#xE3;o histol&#xF3;gico. Enzinger e Smith notaram sobrevida de 77% em 10 anos nos pacientes com 0 a 3 mitoses/10 <italic>versus</italic> 29% naqueles pacientes com 4 ou mais por campo.<sup>(</sup>
<xref rid="B7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> De forma similar, a sobrevida foi de 81% nos pacientes sem necrose tumoral <italic>versus</italic> 29% naqueles que apresentaram &#xE1;reas necr&#xF3;ticas no tumor. Foi ainda constatada import&#xE2;ncia do tamanho do tumor em rela&#xE7;&#xE3;o ao progn&#xF3;stico. Em tumores &lt;6,5cm, a sobrevida em 10 anos alcan&#xE7;ou 95% e foi de 63% para tumores maiores.<sup>(</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>
</p>
      </sec>
      <sec>
        <title>CONCLUS&#xC3;O</title>
        <p>Por ser patologia rara e apresentar-se com quadro cl&#xED;nico vago, associado a exames de imagem que n&#xE3;o indicam uma patologia espec&#xED;fica, o diagn&#xF3;stico exato de hemangiopericitoma d&#xE1;-se apenas no p&#xF3;s-operat&#xF3;rio, com o resultado imuno-histoqu&#xED;mico.</p>
        <p>O melhor tratamento consiste na excis&#xE3;o cir&#xFA;rgica completa, visto que o tratamento complementar, com quimioterapia e/ou radioterapia, n&#xE3;o se mostrou efetivo.</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
